Rothschild & Co Asset Management US’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-436,775
| Closed | -$6.98M | – | 589 |
|
|
2016
Q1 | $6.98M | Buy |
436,775
+11,548
| +3% | +$185K | 0.13% | 230 |
|
|
2015
Q4 | $12.2M | Buy |
425,227
+22,259
| +6% | +$637K | 0.22% | 152 |
|
|
2015
Q3 | $11.5M | Buy |
402,968
+58,572
| +17% | +$1.67M | 0.22% | 155 |
|
|
2015
Q2 | $12.4M | Buy |
344,396
+8,330
| +2% | +$299K | 0.23% | 151 |
|
|
2015
Q1 | $9.77M | Buy |
336,066
+6,446
| +2% | +$187K | 0.19% | 189 |
|
|
2014
Q4 | $6.95M | Sell |
329,620
-8,688
| -3% | -$183K | 0.14% | 218 |
|
|
2014
Q3 | $6.56M | Sell |
338,308
-13,630
| -4% | -$264K | 0.14% | 221 |
|
|
2014
Q2 | $5.5M | Sell |
351,938
-2,172
| -0.6% | -$33.9K | 0.11% | 268 |
|
|
2014
Q1 | $7.34M | Sell |
354,110
-13,558
| -4% | -$281K | 0.16% | 221 |
|
|
2013
Q4 | $4.74M | Buy |
+367,668
| New | +$4.74M | 0.11% | 278 |
|